Exegenesis Bio Inc.递表港交所
Zhi Tong Cai Jing·2026-01-14 22:42
Group 1 - Exegenesis Bio Inc. submitted its listing application to the Hong Kong Stock Exchange on January 14, with CCB International as the sole sponsor [1] - The company has developed a diverse and scalable product pipeline leveraging its proprietary AAVarta and SODA technology platforms [1] - Core candidate product EXG001-307 targets SMA type 1, along with two key candidates EXG102-031 and EXG202 [1]